NATCO Pharma Yönetim
Yönetim kriter kontrolleri 1/4
NATCO Pharma CEO'su Rajeev Nannapaneni, Jun2012 tarihinde atandı, in görev süresi 12.42 yıldır. şirketin hisselerinin 0.63% doğrudan sahiptir ve bu hisselerin değeri ₹ 1.61B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.8 yıl ve 2.3 yıldır.
Anahtar bilgiler
Rajeev Nannapaneni
İcra Kurulu Başkanı
₹98.7m
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | 12.4yrs |
| CEO sahipliği | 0.6% |
| Yönetim ortalama görev süresi | 7.8yrs |
| Yönetim Kurulu ortalama görev süresi | 2.3yrs |
Son yönetim güncellemeleri
Recent updates
We Ran A Stock Scan For Earnings Growth And NATCO Pharma (NSE:NATCOPHARM) Passed With Ease
Oct 13
NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market
Aug 13If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity
Jul 15NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02CEO
Rajeev Nannapaneni (47 yo)
12.4yrs
Görev süresi
₹98,670,000
Tazminat
Sri Rajeev Nannapaneni serves as Chief Executive Officer at NATCO Pharma Limited since April 1, 2022 and also served as Vice Chairman since June 1, 2012 until April 1, 2022 and serves as its Vice Chairman...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| MD & Chairman | 43.2yrs | ₹100.77m | 25.1% ₹ 64.2b | |
| CEO & Vice Chairman | 12.4yrs | ₹98.67m | 0.63% ₹ 1.6b | |
| Chief Financial Officer | 8.8yrs | ₹13.36m | Veri yok | |
| President of Technical Affairs & Whole Time Director | no data | ₹33.69m | 0.030% ₹ 77.3m | |
| Company Secretary & Compliance Officer | 2.6yrs | ₹2.61m | Veri yok | |
| Executive VP of Corporate Engineering Services & Whole Time Director | no data | ₹20.16m | 0.023% ₹ 58.7m | |
| Executive VP of Technical Operations & Director | 7.8yrs | ₹32.12m | 0.013% ₹ 33.2m | |
| VP & Head of Operations | no data | Veri yok | Veri yok | |
| Executive Vice President of Corporate Affairs | no data | Veri yok | Veri yok | |
| Vice President of Marketing & Sales - Domestic | less than a year | Veri yok | Veri yok | |
| Senior Vice President of HR & Organisational Development | no data | Veri yok | 0.0062% ₹ 15.8m | |
| Executive Vice President of R&D | 30.6yrs | Veri yok | 0.025% ₹ 62.9m |
7.8yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim: NATCOPHARM 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.8 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| MD & Chairman | 43.2yrs | ₹100.77m | 25.1% ₹ 64.2b | |
| CEO & Vice Chairman | 19yrs | ₹98.67m | 0.63% ₹ 1.6b | |
| President of Technical Affairs & Whole Time Director | 9.8yrs | ₹33.69m | 0.030% ₹ 77.3m | |
| Executive VP of Corporate Engineering Services & Whole Time Director | 10yrs | ₹20.16m | 0.023% ₹ 58.7m | |
| Executive VP of Technical Operations & Director | 2.3yrs | ₹32.12m | 0.013% ₹ 33.2m | |
| Independent Director | 9.8yrs | ₹330.00k | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok |
2.3yrs
Ortalama Görev Süresi
66yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: NATCOPHARM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.3 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.